Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 4/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 4/20 | 0.50 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.47 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.47 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.43 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.42 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31497321 | 0.98 | KEAP1 (0.51) | CALCRLKEAP1PRMT5WDR77NMUR2 | |
| SCHEMBL31497340 | 0.96 | KEAP1 (0.54) | CALCRLKEAP1PRMT5WDR77NMUR2 | |
| SCHEMBL31497335 | 0.95 | KEAP1 (0.55) | CALCRLKEAP1PRMT5WDR77NMUR2 | |
| SCHEMBL31497333 | 0.94 | CALCRL (0.52) | CALCRLKEAP1PRMT5WDR77KISS1R | |
| SCHEMBL31497341 | 0.93 | CALCRL (0.52) | CALCRLKEAP1PRMT5WDR77CAPN1 | |
| SCHEMBL31497325 | 0.93 | CALCRL (0.52) | CALCRLKEAP1PRMT5WDR77CAPN1 | |
| SCHEMBL31497328 | 0.91 | KEAP1 (0.52) | CALCRLKEAP1PRMT5WDR77NMUR2 | |
| SCHEMBL31497326 | 0.90 | CALCRL (0.46) | CALCRLKEAP1PRMT5WDR77 | |
| SCHEMBL31497369 | 0.87 | KEAP1 (0.48) | CALCRLKEAP1PRMT5WDR77NMUR2 | |
| SCHEMBL9082723 | 0.84 | CALCRL (0.55) | CALCRLKEAP1PRMT5WDR77NMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4545551-A1 | PEPTIDE INHIBITOR AND USE THEREOF | Chengdu Brilliant Inspiration Biotherapeutics Co., Ltd (CN) | 2025-04-30 | — | — | EP | disclosed |